miR-125b reduces the metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) gene expression via neurogenic locus notch homolog protein 1 (NOTCH1) signaling pathway in MM cells, results in more progressiveness of MM and it can be a therapeutic target [20]. This evidence concerns the gene MALAT1 and Miyoshi myopathy.